Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Bevacizumab|DRUG: Letrozole|DRUG: Anastrozole|DRUG: Exemestane|DRUG: Fulvestrant|DRUG: Goserelin|DRUG: leuprorelin
Sponsor: Japan Breast Cancer Research Group
Collaborators: Chugai Pharmaceutical